{
    "id": "68d3990e-f9fb-4686-9491-e2774d4db121",
    "result_metadata": {
        "score": 1
    },
    "copyright": "Copyright \u00a9 2020 NewsRx LLC, NewsRx Pharma Business Daily",
    "geoOrigin": "Atlanta, Georgia",
    "sourceType": "Professional, Business, or Trade Journal",
    "source": "NewsRx Pharma Business Daily",
    "corpus_document_id": "3823086579057067512",
    "description": "2020 JUN 05-- By a News Reporter-Staff News Editor at NewsRx Pharma Business Daily-- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Pra Health Sciences, Inc. was posted on May 26, 2020. The SEC file number is 0001104659-20-065895.. A U.S. Securities and Exchange Commission...",
    "serviceName": "Health Newsletters",
    "locationCode": [
        {
            "parent": "LR/am",
            "relevance_score": "9",
            "description": "North America",
            "code": "LB/nam#9#49#90",
            "level": 1
        },
        {
            "parent": "LB/nam",
            "relevance_score": "9",
            "description": "United States",
            "code": "LC/us#9#50#90",
            "level": 2
        },
        {
            "parent": null,
            "relevance_score": "9",
            "description": "Americas",
            "code": "LR/am#9#49#90",
            "level": 0
        },
        {
            "code": "LR/nam#9#49#90",
            "description": "",
            "relevance_score": "9"
        }
    ],
    "sourceClass": "Pharmaceuticals",
    "subjectCode": [
        {
            "parent": "IS/biz.spec",
            "relevance_score": "7",
            "description": "Corporate Communications",
            "code": "IS/biz.corpcomm#7#50#75",
            "level": 2
        },
        {
            "parent": "IS/biz.corpcomm",
            "relevance_score": "7",
            "description": "Company Regulatory Filings",
            "code": "IS/biz.filings#7#75#50",
            "level": 3
        },
        {
            "parent": "IS/spec",
            "relevance_score": "7",
            "description": "Structured Business and Commerce Content",
            "code": "IS/biz.spec#7#50#75",
            "level": 1
        },
        {
            "parent": null,
            "relevance_score": "7",
            "description": "Structured Content",
            "code": "IS/spec#7#50#75",
            "level": 0
        }
    ],
    "text": "2020 JUN 05 (NewsRx) -- By a News Reporter-Staff News Editor at NewsRx Pharma\nBusiness Daily \\-- According to news reporting originating from Washington,\nD.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC)\nfiling by Pra Health Sciences, Inc. (Form S-8 POS) was posted on May 26, 2020.\n\nThe SIC code for this company is 8731, Commercial Physical and Biological\nResearch.\n\nThe SEC file number is 0001104659-20-065895.\n\nThe contact information for this company is 4130 PARKLAKE AVENUE, SUITE 400,\nRALEIGH NC 27612, 9197868200.\n\nOur editors provided additional information about Form S-8 POS: Securities to\nbe offered to employees pursuant to employee benefit plans: Post-effective\namendments.\n\nA U.S. Securities and Exchange Commission filing is a formal document or\nfinancial statement submitted to the SEC by publicly-traded companies.\n\nFor additional information on this SEC filing see:\n<http://www.sec.gov/Archives/edgar/data/1613859/0001104659-20-065895-index.html>.\n\n(Our reports deliver fact-based news of research and discoveries from around\nthe world.)",
    "industryCode": [],
    "naviga_enrichment": {
        "org": [
            "News Reporter-Staff News",
            "NewsRx Pharma Business Daily",
            "U.S. Securities and Exchange Commission",
            "Pra Health Sciences, Inc.",
            "Commercial Physical and Biological Research",
            "SEC"
        ],
        "location": [
            "Washington, D.C.",
            "RALEIGH NC"
        ],
        "person": [],
        "companies": [
            "News Reporter-Staff News",
            "NewsRx Pharma Business Daily",
            "Commercial Physical and Biological Research",
            "U.S. Securities and Exchange Commission",
            "SEC",
            "Pra Health Sciences, Inc."
        ]
    },
    "geoOrigin_code": "RU/us.ga.atlnta",
    "language": "English",
    "filename": "202006050000NEWSRX__HLTHNWLR_456A3C13F8018EED.XML",
    "providerName": "NewsRx.com",
    "enriched_text": {
        "entities": [
            {
                "count": 6,
                "sentiment": {
                    "score": -0.459654,
                    "label": "negative"
                },
                "text": "U.S. Securities and Exchange Commission",
                "relevance": 0.814079,
                "type": "Organization",
                "disambiguation": {
                    "subtype": [
                        "GovernmentAgency",
                        "GovernmentalBody"
                    ],
                    "name": "U.S. Securities and Exchange Commission",
                    "dbpedia_resource": "http://dbpedia.org/resource/U.S._Securities_and_Exchange_Commission"
                }
            },
            {
                "count": 1,
                "sentiment": {
                    "score": 0,
                    "label": "neutral"
                },
                "text": "NewsRx Pharma",
                "relevance": 0.534263,
                "type": "Company"
            },
            {
                "count": 1,
                "sentiment": {
                    "score": 0,
                    "label": "neutral"
                },
                "text": "News Editor",
                "relevance": 0.31668,
                "type": "JobTitle"
            },
            {
                "count": 1,
                "sentiment": {
                    "score": 0,
                    "label": "neutral"
                },
                "text": "Pra Health Sciences",
                "relevance": 0.30438,
                "type": "Organization"
            },
            {
                "count": 1,
                "sentiment": {
                    "score": -0.41765,
                    "label": "negative"
                },
                "text": "Commercial Physical and Biological",
                "relevance": 0.264845,
                "type": "PrintMedia"
            },
            {
                "count": 1,
                "sentiment": {
                    "score": 0,
                    "label": "neutral"
                },
                "text": "Washington",
                "relevance": 0.264624,
                "type": "Location",
                "disambiguation": {
                    "subtype": [
                        "AdministrativeDivision",
                        "GovernmentalJurisdiction",
                        "MilitaryPost",
                        "PlaceWithNeighborhoods",
                        "USCounty",
                        "City"
                    ],
                    "name": "Washington, D.C.",
                    "dbpedia_resource": "http://dbpedia.org/resource/Washington,_D.C."
                }
            },
            {
                "count": 1,
                "sentiment": {
                    "score": -0.601957,
                    "label": "negative"
                },
                "text": "SIC",
                "relevance": 0.253479,
                "type": "Company"
            },
            {
                "count": 1,
                "sentiment": {
                    "score": 0,
                    "label": "neutral"
                },
                "text": "RALEIGH",
                "relevance": 0.244659,
                "type": "Location",
                "disambiguation": {
                    "subtype": [
                        "PlaceWithNeighborhoods",
                        "City"
                    ],
                    "name": "Raleigh, North Carolina",
                    "dbpedia_resource": "http://dbpedia.org/resource/Raleigh,_North_Carolina"
                }
            },
            {
                "count": 1,
                "sentiment": {
                    "score": 0,
                    "label": "neutral"
                },
                "text": "NC",
                "relevance": 0.221898,
                "type": "Location",
                "disambiguation": {
                    "subtype": [
                        "StateOrCounty"
                    ]
                }
            },
            {
                "count": 1,
                "sentiment": {
                    "score": 0.491659,
                    "label": "positive"
                },
                "text": "D.C.",
                "relevance": 0.20128,
                "type": "Location",
                "disambiguation": {
                    "subtype": [
                        "City"
                    ]
                }
            }
        ],
        "semantic_roles": [
            {
                "subject": {
                    "text": "Business Daily \\--"
                },
                "sentence": " Business Daily \\-- According to news reporting originating from Washington,",
                "object": {
                    "text": "to news reporting originating from Washington,"
                },
                "action": {
                    "verb": {
                        "text": "According",
                        "tense": "present"
                    },
                    "text": "According",
                    "normalized": "According"
                }
            },
            {
                "subject": {
                    "text": "The SIC code for this company"
                },
                "sentence": " The SIC code for this company is 8731, Commercial Physical and Biological",
                "object": {
                    "text": "8731, Commercial Physical and Biological"
                },
                "action": {
                    "verb": {
                        "text": "be",
                        "tense": "present"
                    },
                    "text": "is",
                    "normalized": "be"
                }
            },
            {
                "subject": {
                    "text": "The SEC file number"
                },
                "sentence": " The SEC file number is 0001104659-20-065895.",
                "object": {
                    "text": "0001104659-20-065895"
                },
                "action": {
                    "verb": {
                        "text": "be",
                        "tense": "present"
                    },
                    "text": "is",
                    "normalized": "be"
                }
            },
            {
                "subject": {
                    "text": "The contact information for this company"
                },
                "sentence": " The contact information for this company is 4130 PARKLAKE AVENUE, SUITE 400,",
                "object": {
                    "text": "4130 PARKLAKE AVENUE, SUITE 400,"
                },
                "action": {
                    "verb": {
                        "text": "be",
                        "tense": "present"
                    },
                    "text": "is",
                    "normalized": "be"
                }
            },
            {
                "subject": {
                    "text": "Our editors"
                },
                "sentence": " Our editors provided additional information about Form S-8 POS: Securities to",
                "object": {
                    "text": "additional information about Form S-8 POS"
                },
                "action": {
                    "verb": {
                        "text": "provide",
                        "tense": "past"
                    },
                    "text": "provided",
                    "normalized": "provide"
                }
            },
            {
                "subject": {
                    "text": "pursuant to employee benefit plans"
                },
                "sentence": " be offered to employees pursuant to employee benefit plans: Post-effective",
                "object": {
                    "text": "to employees"
                },
                "action": {
                    "verb": {
                        "text": "offer",
                        "tense": "past"
                    },
                    "text": "be offered",
                    "normalized": "be offer"
                }
            },
            {
                "subject": {
                    "text": "A U.S. Securities and Exchange Commission filing"
                },
                "sentence": " A U.S. Securities and Exchange Commission filing is a formal document or",
                "object": {
                    "text": "a formal document"
                },
                "action": {
                    "verb": {
                        "text": "be",
                        "tense": "present"
                    },
                    "text": "is",
                    "normalized": "be"
                }
            },
            {
                "subject": {
                    "text": "by publicly-traded companies"
                },
                "sentence": " financial statement submitted to the SEC by publicly-traded companies.",
                "object": {
                    "text": "financial statement"
                },
                "action": {
                    "verb": {
                        "text": "submit",
                        "tense": "past"
                    },
                    "text": "submitted",
                    "normalized": "submit"
                }
            },
            {
                "subject": {
                    "text": "Our reports"
                },
                "sentence": " (Our reports deliver fact-based news of research and discoveries from around",
                "object": {
                    "text": "fact-based news of research and discoveries"
                },
                "action": {
                    "verb": {
                        "text": "deliver",
                        "tense": "present"
                    },
                    "text": "deliver",
                    "normalized": "deliver"
                }
            }
        ],
        "categories": [
            {
                "score": 0.941612,
                "label": "/finance/financial news"
            },
            {
                "score": 0.774973,
                "label": "/finance/investing"
            },
            {
                "score": 0.774973,
                "label": "/finance/investing/beginning investing"
            }
        ],
        "relations": [
            {
                "type": "employedBy",
                "sentence": "2020 JUN 05 (NewsRx) -- By a News Reporter-Staff News Editor at NewsRx Pharma Business Daily \\-- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Pra Health Sciences, Inc. (Form S-8 POS) was posted on May 26, 2020.",
                "score": 0.496824,
                "arguments": [
                    {
                        "text": "Editor",
                        "location": [
                            54,
                            60
                        ],
                        "entities": [
                            {
                                "type": "Person",
                                "text": "Reporter"
                            }
                        ]
                    },
                    {
                        "text": "Staff News",
                        "location": [
                            43,
                            53
                        ],
                        "entities": [
                            {
                                "type": "Organization",
                                "text": "Staff News"
                            }
                        ]
                    }
                ]
            },
            {
                "type": "agentOf",
                "sentence": "A U.S. Securities and Exchange Commission filing is a formal document or financial statement submitted to the SEC by publicly-traded companies.",
                "score": 0.937194,
                "arguments": [
                    {
                        "text": "Securities and Exchange Commission",
                        "location": [
                            723,
                            757
                        ],
                        "entities": [
                            {
                                "type": "Organization",
                                "text": "Securities and Exchange Commission",
                                "disambiguation": {
                                    "subtype": [
                                        "Government"
                                    ]
                                }
                            }
                        ]
                    },
                    {
                        "text": "filing",
                        "location": [
                            758,
                            764
                        ],
                        "entities": [
                            {
                                "type": "EventLegal",
                                "text": "filing"
                            }
                        ]
                    }
                ]
            },
            {
                "type": "agentOf",
                "sentence": "For additional information on this SEC filing see: <http://www.sec.gov/Archives/edgar/data/1613859/0001104659-20-065895-index.html>.",
                "score": 0.715331,
                "arguments": [
                    {
                        "text": "SEC",
                        "location": [
                            896,
                            899
                        ],
                        "entities": [
                            {
                                "type": "Organization",
                                "text": "Securities and Exchange Commission",
                                "disambiguation": {
                                    "subtype": [
                                        "Government"
                                    ]
                                }
                            }
                        ]
                    },
                    {
                        "text": "filing",
                        "location": [
                            900,
                            906
                        ],
                        "entities": [
                            {
                                "type": "EventLegal",
                                "text": "filing"
                            }
                        ]
                    }
                ]
            },
            {
                "type": "partOf",
                "sentence": "A U.S. Securities and Exchange Commission filing is a formal document or financial statement submitted to the SEC by publicly-traded companies.",
                "score": 0.470678,
                "arguments": [
                    {
                        "text": "companies",
                        "location": [
                            849,
                            858
                        ],
                        "entities": [
                            {
                                "type": "Organization",
                                "text": "companies",
                                "disambiguation": {
                                    "subtype": [
                                        "Commercial"
                                    ]
                                }
                            }
                        ]
                    },
                    {
                        "text": "SEC",
                        "location": [
                            826,
                            829
                        ],
                        "entities": [
                            {
                                "type": "Organization",
                                "text": "Securities and Exchange Commission",
                                "disambiguation": {
                                    "subtype": [
                                        "Government"
                                    ]
                                }
                            }
                        ]
                    }
                ]
            },
            {
                "type": "employedBy",
                "sentence": "2020 JUN 05 (NewsRx) -- By a News Reporter-Staff News Editor at NewsRx Pharma Business Daily \\-- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Pra Health Sciences, Inc. (Form S-8 POS) was posted on May 26, 2020.",
                "score": 0.807012,
                "arguments": [
                    {
                        "text": "Editor",
                        "location": [
                            54,
                            60
                        ],
                        "entities": [
                            {
                                "type": "Person",
                                "text": "Reporter"
                            }
                        ]
                    },
                    {
                        "text": "NewsRx Pharma\nBusiness Daily \\",
                        "location": [
                            64,
                            94
                        ],
                        "entities": [
                            {
                                "type": "Organization",
                                "text": "NewsRx Pharma\nBusiness Daily \\",
                                "disambiguation": {
                                    "subtype": [
                                        "Commercial"
                                    ]
                                }
                            }
                        ]
                    }
                ]
            },
            {
                "type": "locatedAt",
                "sentence": "2020 JUN 05 (NewsRx) -- By a News Reporter-Staff News Editor at NewsRx Pharma Business Daily \\-- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Pra Health Sciences, Inc. (Form S-8 POS) was posted on May 26, 2020.",
                "score": 0.987561,
                "arguments": [
                    {
                        "text": "Washington",
                        "location": [
                            142,
                            152
                        ],
                        "entities": [
                            {
                                "type": "GeopoliticalEntity",
                                "text": "Washington"
                            }
                        ]
                    },
                    {
                        "text": "D.C.",
                        "location": [
                            154,
                            158
                        ],
                        "entities": [
                            {
                                "type": "GeopoliticalEntity",
                                "text": "D.C."
                            }
                        ]
                    }
                ]
            },
            {
                "type": "employedBy",
                "sentence": "2020 JUN 05 (NewsRx) -- By a News Reporter-Staff News Editor at NewsRx Pharma Business Daily \\-- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Pra Health Sciences, Inc. (Form S-8 POS) was posted on May 26, 2020.",
                "score": 0.838621,
                "arguments": [
                    {
                        "text": "journalists",
                        "location": [
                            170,
                            181
                        ],
                        "entities": [
                            {
                                "type": "Person",
                                "text": "journalists"
                            }
                        ]
                    },
                    {
                        "text": "NewsRx",
                        "location": [
                            163,
                            169
                        ],
                        "entities": [
                            {
                                "type": "Organization",
                                "text": "NewsRx Pharma\nBusiness Daily \\",
                                "disambiguation": {
                                    "subtype": [
                                        "Commercial"
                                    ]
                                }
                            }
                        ]
                    }
                ]
            },
            {
                "type": "partOf",
                "sentence": "2020 JUN 05 (NewsRx) -- By a News Reporter-Staff News Editor at NewsRx Pharma Business Daily \\-- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Pra Health Sciences, Inc. (Form S-8 POS) was posted on May 26, 2020.",
                "score": 0.944136,
                "arguments": [
                    {
                        "text": "Securities and Exchange Commission",
                        "location": [
                            190,
                            224
                        ],
                        "entities": [
                            {
                                "type": "Organization",
                                "text": "Securities and Exchange Commission",
                                "disambiguation": {
                                    "subtype": [
                                        "Government"
                                    ]
                                }
                            }
                        ]
                    },
                    {
                        "text": "U.S.",
                        "location": [
                            185,
                            189
                        ],
                        "entities": [
                            {
                                "type": "GeopoliticalEntity",
                                "text": "U.S.",
                                "disambiguation": {
                                    "subtype": [
                                        "Country"
                                    ]
                                }
                            }
                        ]
                    }
                ]
            },
            {
                "type": "partOf",
                "sentence": "A U.S. Securities and Exchange Commission filing is a formal document or financial statement submitted to the SEC by publicly-traded companies.",
                "score": 0.892427,
                "arguments": [
                    {
                        "text": "Securities and Exchange Commission",
                        "location": [
                            723,
                            757
                        ],
                        "entities": [
                            {
                                "type": "Organization",
                                "text": "Securities and Exchange Commission",
                                "disambiguation": {
                                    "subtype": [
                                        "Government"
                                    ]
                                }
                            }
                        ]
                    },
                    {
                        "text": "U.S.",
                        "location": [
                            718,
                            722
                        ],
                        "entities": [
                            {
                                "type": "GeopoliticalEntity",
                                "text": "U.S.",
                                "disambiguation": {
                                    "subtype": [
                                        "Country"
                                    ]
                                }
                            }
                        ]
                    }
                ]
            },
            {
                "type": "locatedAt",
                "sentence": "The contact information for this company is 4130 PARKLAKE AVENUE, SUITE 400, RALEIGH NC 27612, 9197868200.",
                "score": 0.376101,
                "arguments": [
                    {
                        "text": "company",
                        "location": [
                            475,
                            482
                        ],
                        "entities": [
                            {
                                "type": "Organization",
                                "text": "NewsRx Pharma\nBusiness Daily \\",
                                "disambiguation": {
                                    "subtype": [
                                        "Commercial"
                                    ]
                                }
                            }
                        ]
                    },
                    {
                        "text": "PARKLAKE AVENUE",
                        "location": [
                            491,
                            506
                        ],
                        "entities": [
                            {
                                "type": "Facility",
                                "text": "PARKLAKE AVENUE"
                            }
                        ]
                    }
                ]
            },
            {
                "type": "locatedAt",
                "sentence": "The contact information for this company is 4130 PARKLAKE AVENUE, SUITE 400, RALEIGH NC 27612, 9197868200.",
                "score": 0.811703,
                "arguments": [
                    {
                        "text": "PARKLAKE AVENUE",
                        "location": [
                            491,
                            506
                        ],
                        "entities": [
                            {
                                "type": "Facility",
                                "text": "PARKLAKE AVENUE"
                            }
                        ]
                    },
                    {
                        "text": "SUITE 400",
                        "location": [
                            508,
                            517
                        ],
                        "entities": [
                            {
                                "type": "Facility",
                                "text": "SUITE 400"
                            }
                        ]
                    }
                ]
            },
            {
                "type": "employedBy",
                "sentence": "Our editors provided additional information about Form S-8 POS: Securities to be offered to employees pursuant to employee benefit plans: Post-effective amendments.",
                "score": 0.457128,
                "arguments": [
                    {
                        "text": "editors",
                        "location": [
                            554,
                            561
                        ],
                        "entities": [
                            {
                                "type": "Person",
                                "text": "editors"
                            }
                        ]
                    },
                    {
                        "text": "Our",
                        "location": [
                            550,
                            553
                        ],
                        "entities": [
                            {
                                "type": "Organization",
                                "text": "Staff News"
                            }
                        ]
                    }
                ]
            },
            {
                "type": "agentOf",
                "sentence": "Our editors provided additional information about Form S-8 POS: Securities to be offered to employees pursuant to employee benefit plans: Post-effective amendments.",
                "score": 0.982062,
                "arguments": [
                    {
                        "text": "editors",
                        "location": [
                            554,
                            561
                        ],
                        "entities": [
                            {
                                "type": "Person",
                                "text": "editors"
                            }
                        ]
                    },
                    {
                        "text": "provided",
                        "location": [
                            562,
                            570
                        ],
                        "entities": [
                            {
                                "type": "EventCommunication",
                                "text": "provided"
                            }
                        ]
                    }
                ]
            }
        ],
        "keywords": [
            {
                "text": "News Reporter-Staff News Editor",
                "relevance": 0.902724,
                "count": 1
            },
            {
                "text": "contact information",
                "relevance": 0.676893,
                "count": 1
            },
            {
                "text": "additional information",
                "relevance": 0.668024,
                "count": 2
            },
            {
                "text": "SEC file number",
                "relevance": 0.666503,
                "count": 1
            },
            {
                "text": "financial statement",
                "relevance": 0.637076,
                "count": 1
            },
            {
                "text": "Exchange Commission",
                "relevance": 0.634558,
                "count": 1
            },
            {
                "text": "NewsRx journalists",
                "relevance": 0.59785,
                "count": 1
            },
            {
                "text": "U.S. Securities",
                "relevance": 0.596259,
                "count": 2
            },
            {
                "text": "Pra Health Sciences",
                "relevance": 0.570959,
                "count": 1
            },
            {
                "text": "SIC code",
                "relevance": 0.559253,
                "count": 1
            },
            {
                "text": "SEC",
                "relevance": 0.555973,
                "count": 2
            },
            {
                "text": "reports",
                "relevance": 0.553774,
                "count": 1
            },
            {
                "text": "JUN",
                "relevance": 0.542109,
                "count": 1
            },
            {
                "text": "Form S-8 POS",
                "relevance": 0.541621,
                "count": 2
            },
            {
                "text": "editors",
                "relevance": 0.531683,
                "count": 1
            },
            {
                "text": "news",
                "relevance": 0.529598,
                "count": 1
            },
            {
                "text": "employees",
                "relevance": 0.527677,
                "count": 1
            },
            {
                "text": "news of research",
                "relevance": 0.521261,
                "count": 1
            },
            {
                "text": "fact",
                "relevance": 0.520955,
                "count": 1
            },
            {
                "text": "company",
                "relevance": 0.519845,
                "count": 2
            },
            {
                "text": "Securities",
                "relevance": 0.51303,
                "count": 1
            },
            {
                "text": "world",
                "relevance": 0.507159,
                "count": 1
            },
            {
                "text": "discoveries",
                "relevance": 0.507159,
                "count": 1
            },
            {
                "text": "SUITE",
                "relevance": 0.507159,
                "count": 1
            },
            {
                "text": "Washington",
                "relevance": 0.507159,
                "count": 1
            },
            {
                "text": "companies",
                "relevance": 0.506618,
                "count": 1
            },
            {
                "text": "employee benefit plans",
                "relevance": 0.499187,
                "count": 1
            },
            {
                "text": "Exchange Commission filing",
                "relevance": 0.493548,
                "count": 1
            },
            {
                "text": "SEC filing",
                "relevance": 0.478431,
                "count": 1
            },
            {
                "text": "RALEIGH NC",
                "relevance": 0.477267,
                "count": 1
            },
            {
                "text": "PARKLAKE AVENUE",
                "relevance": 0.470223,
                "count": 1
            },
            {
                "text": "Commercial Physical",
                "relevance": 0.470223,
                "count": 1
            },
            {
                "text": "NewsRx",
                "relevance": 0.466048,
                "count": 1
            },
            {
                "text": "formal document",
                "relevance": 0.45833,
                "count": 1
            },
            {
                "text": "D.C.",
                "relevance": 0.439012,
                "count": 1
            },
            {
                "text": "Inc.",
                "relevance": 0.416839,
                "count": 1
            },
            {
                "text": "May",
                "relevance": 0.41012,
                "count": 1
            }
        ]
    },
    "freqeuncy": "Weekly",
    "extracted_metadata": {
        "sha1": "3af8846d917225f86c2d049ea600ab1c4418f4d6",
        "filename": "202006050000NEWSRX__HLTHNWLR_456A3C13F8018EED.json",
        "file_type": "json"
    },
    "companyRecord": "NASDAQ-NMS|PRAH|CUSIP:69354M108;ISIN:US69354M1080|Pra Health Sciences Inc|extractor|DUNS:079571062;NECOID:1626806505;ACORN:1615806505|SIGNIFICANT||||XNAS|REFERENCE",
    "publicationTime": "2020-06-05T00:00:00-04:00",
    "title": "Pra Health Sciences, Inc. Files SEC Form S-8 POS, Securities To Be Offered To Employees in Employee Benefit Plans, Post-effective Amendments: (May 26, 2020): Pra Health Sciences Inc.",
    "html": "<p>2020 JUN 05 (NewsRx) -- By a <org>News Reporter-Staff News</org> Editor at <org>NewsRx Pharma Business Daily</org> -- According to news reporting originating from <location idsrc=\"xmltag.org\" value=\"LU/us.dc.wash\">Washington, D.C.</location>, by NewsRx journalists, a <org idsrc=\"xmltag.org\" value=\"ACORN:0964256832\">U.S. Securities and Exchange Commission</org> (SEC) filing by <org idsrc=\"xmltag.org\" value=\"NASDAQ-NMS:PRAH\">Pra Health Sciences, Inc.</org> (Form S-8 POS) was posted on <chron>May 26, 2020</chron>.</p>\n<p>The SIC code for this company is 8731, <org>Commercial Physical and Biological Research</org>.</p>\n<p>The <org>SEC</org> file number is 0001104659-20-065895.</p>\n<p>The contact information for this company is 4130 PARKLAKE AVENUE, SUITE 400, <location idsrc=\"xmltag.org\" value=\"LU/us.nc.raleig\">RALEIGH NC</location> 27612, 9197868200.</p>\n<p>Our editors provided additional information about Form S-8 POS: Securities to be offered to employees pursuant to employee benefit plans: Post-effective amendments.</p>\n<p>A <org idsrc=\"xmltag.org\" value=\"ACORN:0964256832\">U.S. Securities and Exchange Commission</org> filing is a formal document or financial statement submitted to the <org>SEC</org> by publicly-traded companies.</p>\n<p>For additional information on this <org>SEC</org> filing see: <a href=\"http://www.sec.gov/Archives/edgar/data/1613859/0001104659-20-065895-index.html\" target=\"_blank\">http://www.sec.gov/Archives/edgar/data/1613859/0001104659-20-065895-index.html</a>.</p>\n<p />\n<p class=\"shirttail\">(Our reports deliver fact-based news of research and discoveries from around the world.)</p>\n<p />",
    "geoFocus": [
        [
            "GR/glb",
            "Global"
        ]
    ]
}